As previously described, the impairment of endothelium-dependent vasodilation in patients with diabetes is due to the impaired NO bioavailability [6], and endoglin expression and NO regulation are intimately related, as we have demonstrated that endoglin plays a major role in regulating eNOS abundance and NO synthesis regulation based on two different mechanisms. Here, NOS3 is linked to diabetes mellitus.